Frailty Screening in Chronic Kidney Disease: Current Perspectives

George Worthen,1 Karthik Tennankore2 1Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada; 2Division of Nephrology, Nova Scotia Health Authority, Halifax, NS, CanadaCorrespondence: Karthik TennankoreDivision of Nephrology, QEII - Dickson Building, Suite 5090 Dickson Building, 5...

Full description

Bibliographic Details
Main Authors: Worthen G, Tennankore K
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:International Journal of Nephrology and Renovascular Disease
Subjects:
Online Access:https://www.dovepress.com/frailty-screening-in-chronic-kidney-disease-current-perspectives-peer-reviewed-article-IJNRD
id doaj-e5186672303d45049cc425e68ff5cc9a
record_format Article
spelling doaj-e5186672303d45049cc425e68ff5cc9a2020-11-25T00:10:59ZengDove Medical PressInternational Journal of Nephrology and Renovascular Disease1178-70582019-12-01Volume 1222923950271Frailty Screening in Chronic Kidney Disease: Current PerspectivesWorthen GTennankore KGeorge Worthen,1 Karthik Tennankore2 1Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada; 2Division of Nephrology, Nova Scotia Health Authority, Halifax, NS, CanadaCorrespondence: Karthik TennankoreDivision of Nephrology, QEII - Dickson Building, Suite 5090 Dickson Building, 5820 University Avenue, Halifax, NS B3H 2Y9, CanadaTel +1 902-473-2099Fax +1 902-473-2675Email KarthikK.Tennankore@nshealth.caAbstract: Frailty has been defined as a state of increased vulnerability as a consequence of deficit accumulation. Frailty screening has not yet been widely implemented into routine nephrology care. Patients with chronic kidney disease (CKD) are at high risk of being frail, and frailty has been associated with worse outcomes in this population. Standard management of CKD, including initiation of renal replacement therapies, may have decreased benefit or potentially cause harm in the presence of frailty, and a variety of interventions for modifying frailty in the CKD population have been proposed. The optimal means of screening for frailty in patients with kidney disease remains unclear. This review highlights the value of frailty screening in CKD by summarizing the outcomes associated with frailty and exploring proposed changes to the management of frail patients with CKD. Finally, we will propose a framework for how to implement frailty screening into standard nephrology care.Keywords: geriatrics, sarcopenia, transplant, dialysis, conservative managementhttps://www.dovepress.com/frailty-screening-in-chronic-kidney-disease-current-perspectives-peer-reviewed-article-IJNRDgeriatricssarcopeniatransplantdialysisconservative management
collection DOAJ
language English
format Article
sources DOAJ
author Worthen G
Tennankore K
spellingShingle Worthen G
Tennankore K
Frailty Screening in Chronic Kidney Disease: Current Perspectives
International Journal of Nephrology and Renovascular Disease
geriatrics
sarcopenia
transplant
dialysis
conservative management
author_facet Worthen G
Tennankore K
author_sort Worthen G
title Frailty Screening in Chronic Kidney Disease: Current Perspectives
title_short Frailty Screening in Chronic Kidney Disease: Current Perspectives
title_full Frailty Screening in Chronic Kidney Disease: Current Perspectives
title_fullStr Frailty Screening in Chronic Kidney Disease: Current Perspectives
title_full_unstemmed Frailty Screening in Chronic Kidney Disease: Current Perspectives
title_sort frailty screening in chronic kidney disease: current perspectives
publisher Dove Medical Press
series International Journal of Nephrology and Renovascular Disease
issn 1178-7058
publishDate 2019-12-01
description George Worthen,1 Karthik Tennankore2 1Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada; 2Division of Nephrology, Nova Scotia Health Authority, Halifax, NS, CanadaCorrespondence: Karthik TennankoreDivision of Nephrology, QEII - Dickson Building, Suite 5090 Dickson Building, 5820 University Avenue, Halifax, NS B3H 2Y9, CanadaTel +1 902-473-2099Fax +1 902-473-2675Email KarthikK.Tennankore@nshealth.caAbstract: Frailty has been defined as a state of increased vulnerability as a consequence of deficit accumulation. Frailty screening has not yet been widely implemented into routine nephrology care. Patients with chronic kidney disease (CKD) are at high risk of being frail, and frailty has been associated with worse outcomes in this population. Standard management of CKD, including initiation of renal replacement therapies, may have decreased benefit or potentially cause harm in the presence of frailty, and a variety of interventions for modifying frailty in the CKD population have been proposed. The optimal means of screening for frailty in patients with kidney disease remains unclear. This review highlights the value of frailty screening in CKD by summarizing the outcomes associated with frailty and exploring proposed changes to the management of frail patients with CKD. Finally, we will propose a framework for how to implement frailty screening into standard nephrology care.Keywords: geriatrics, sarcopenia, transplant, dialysis, conservative management
topic geriatrics
sarcopenia
transplant
dialysis
conservative management
url https://www.dovepress.com/frailty-screening-in-chronic-kidney-disease-current-perspectives-peer-reviewed-article-IJNRD
work_keys_str_mv AT wortheng frailtyscreeninginchronickidneydiseasecurrentperspectives
AT tennankorek frailtyscreeninginchronickidneydiseasecurrentperspectives
_version_ 1725405849283723264